Home > Insider Trading > Filing (0001209191-16-105840)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591313	R John Desjarlais	C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016	Sr. V.p., Research & Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-03-02	28,653	$0.59	57,709	No	4	M	Direct
Common Stock	Disposition	2016-03-02	11,625	$12.01	46,084	No	4	S	Direct
Common Stock	Acquisiton	2016-03-03	6,888	$0.59	52,972	No	4	M	Direct
Common Stock	Disposition	2016-03-03	2,635	$12.00	50,337	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-03-02	28,653	$0.00	28,653	$0.59
Common Stock	Stock Option (right to buy)	Disposition	2016-03-03	6,888	$0.00	6,888	$0.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,888		2016-12-31	No	4	M	Direct
0		2016-12-31	No	4	M	Direct

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted December 14, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The stock option is fully vested and exercisable.